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Mental retardation in Down syndrome (DS), the most frequent trisomy in humans, varies from moderate to
severe. Several studies both in human and based on mouse models identified some regions of human
chromosome 21 (Hsa21) as linked to cognitive deficits. However, other intervals such as the telomeric
region of Hsa21 may contribute to the DS phenotype but their role has not yet been investigated in detail.
Here we show that the trisomy of the 12 genes, found in the 0.59 Mb (Abcg1–U2af1) Hsa21 sub-telomeric
region, in mice (Ts1Yah) produced defects in novel object recognition, open-field and Y-maze tests, similar
to other DS models, but induces an improvement of the hippocampal-dependent spatial memory in the
Morris water maze along with enhanced and longer lasting long-term potentiation in vivo in the hippocampus.
Overall, we demonstrate the contribution of the Abcg1–U2af1 genetic region to cognitive defect in working
and short-term recognition memory in DS models. Increase in copy number of the Abcg1–U2af1 interval
leads to an unexpected gain of cognitive function in spatial learning. Expression analysis pinpoints several
genes, such as Ndufv3, Wdr4, Pknox1 and Cbs, as candidates whose overexpression in the hippocampus
might facilitate learning and memory in Ts1Yah mice. Our work unravels the complexity of combinatorial gen-
etic code modulating different aspect of mental retardation in DS patients. It establishes definitely the con-
tribution of the Abcg1–U2af1 orthologous region to the DS etiology and suggests new modulatory
pathways for learning and memory.
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INTRODUCTION
Down syndrome (DS; OMIN #190685) is a complex disorder
associated with the trisomy of human chromosome 21 (Hsa21)
(1). This condition is a paradigm of human aneuploid dis-
orders with supernumerary copies of a chromosome and
could be considered as a prototype of the ‘disorders of the
genome’. DS represents one-third of the cases of mental retar-
dation and cognitive impairment in school-aged children
(2–4) and is associated with a large panel of dysmorphologies,
such as a characteristic facies, skeletal anomalies and brain
alterations at the level of the prefrontal cortex, the hippo-
campus and the cerebellum. DS clinical features also include
developmental delay, metabolic defects and other symptoms
and associated diseases, but their overall expressivity and
penetrance are highly variable.
DS is due to the presence of an additional copy of genetic
elements that are dosage sensitive leading to an abnormal
gene expression level, and/or to the abnormal number of
copies of non-protein coding functional sequences. Further-
more, the effect of some dosage-sensitive genes on the pheno-
type might be allele specific or could depend on the
combination of alleles with qualitative (alleles with amino
acid variation) or quantitative (alleles with variation in gene
expression level) traits (1). It can also be direct or indirect,
taking into account the interaction of aneuploid genes or
gene products with non-aneuploid genes or gene products.
These hypotheses are currently put forward to explain the
variability of the DS alterations, including the most frequent
one, affecting learning and memory that vary from moderate
to severe. The detailed studies of patients carrying partial
duplications of Hsa21 clearly show the contribution of
several regions to specific DS phenotypes (5–8).
During the past 20 years, the efforts have been directed to
understand the pathogenetic mechanisms translating trisomy
of specific genes or genetic regions. To this end, several DS
mouse models have been generated and investigated (9–12).
These include the transchromosomic Tc1 mouse (10), trisomic
(Ts) for the entire Hsa21 and four models encompassing
different nested regions of Mus Musculus (Mmu) chromosome
16 (Mmu16) homologous to Hsa21: Ts65Dn (13), Ts1Cje
(14), Ts1Rhr (15) and Ts1Yu (16). Three of those are Ts for
subregions located on Mmu16, including, respectively, 132
genes from Mrpl39 to Zfp295 in Ts65Dn, 85 from Sfrs15 to
Zfp295 in Ts1Cje and finally 33 genes on a smaller segment
delimited by Cbr and Mx2 (Ts1RhR), whereas Ts1Yu encom-
passes the complete homologous region on Mmu16. These
models show DS-related phenotypes including cognitive and
behavioral impairments, and craniofacial and cardiovascular
malformations related to DS phenotypes, although their inten-
sity was not related to the length of the Ts region (9–11,17–
23). Using such models, the hypothesis on the major role of a
critical region inducing the DS alterations was reviewed
recently (15,24) confirming data obtained in human (5,7,8).
Accordingly, the Tc1 mouse model, containing a nearly com-
plete extra Hsa21, displays additional phenotypes affecting
craniofacial morphology, cognitive function and brain physi-
ology, although the cognitive phenotypes are milder and
more oriented toward locomotor deficit (10,25,26). Altogether
these data enlighten the involvement of regions located
upstream the Mrpl39 gene and downstream Zfp295, in the
telomeric part of Hsa21 in DS phenotypes.
Mouse models available up to now leave unexplored the
contribution of the gene-rich telomeric part of the Hsa21
that maps to the Mmu17 and Mmu10 and do not completely
explain the complexity and variability of some phenotypes
observed in DS patients. Thus, additional Ts models are
needed to evaluate the contribution of genes or other func-
tional elements within the complete Hsa21 to DS phenotypes
(1,8). In the present study, we wanted to evaluate the contri-
bution of the Abcg1–U2af1 genetic interval from the telo-
meric part of Hsa21. To this end, we have generated a new
DS mouse model, the Ts1Yah and the corresponding monoso-
mic (Ms) model, the Ms2Yah. Defects in Ts animals were
scored in the open-field, the Y-maze and novel object recog-
nition (NOR) tests. But, unexpectedly, an improvement of
the spatial reference memory in the Morris water maze
(MWM) and a stronger in vivo long-term potentiation (LTP)
in the hippocampus were detected in Ts mice. Most of the
genes on the Abcg1–U2af1 interval were dosage sensitive
and their change in copy number induced changes in
expression levels of the encoded proteins along with pheno-
typic alterations. Overall, our observation definitely changes
our concept of trisomy, modifying our view of the conse-
quence of increased gene dosage and will have a strong
impact on the identification of pathways to improve learning
and memory in patients.
RESULTS
Generating a targeted segmental duplication and deletion
of the Abcg1–U2af1 genetic interval
We used chromosomal engineering (reviewed in 27) based on
the MICER system (28) to produce in vitro the segmental
duplication and the corresponding deletion of the Abcg1–
U2af1 0.59 Mb interval located on Mmu17. Using an embryo-
nic stem (ES) cells clone carrying both the 50- and 30-Hrpt
vectors inserted at the level of the Abcg1 and upstream of
the U2af1 gene in a cis configuration [Cis(Abcg1tm1Yah–
U2af1tm1Yah)], we were able to generate the segmental dupli-
cation and the deletion, after Cre expression in the G2
phase. Derived aneuploid mouse models correspond to the del-
etion and the reciprocal tandem duplication of the correspond-
ing target region, namely Ts1Yah for the trisomy and Ms2Yah
for the monosomy of the Abcg1–U2af1 region (Fig. 1A and
B). Confirmation of the genomic rearrangements was obtained
using Southern blot analysis (Fig. 1C) and FISH (Fig. 1D).
Both Ts and Ms mice were fully viable and fertile after up
to seven backcrosses on the C57BL6/J background.
Evaluation of motor activity, exploratory behavior,
anxiety, learning and memory in Ts1Yah mice
No significant differences in motor coordination, motor learn-
ing, balance or muscular tonus were detected between Ts1Yah
and diploid mice on the rotarod and the treadmill tests
(Fig. 2A and B), thus suggesting that the Abcg1–U2af1
genetic interval does not contribute to the DS locomotor
defects. Activity pattern and exploratory behavior were evalu-
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Figure 1. Generating a 0.59 Mb deletion and duplication between the Abcg1 and U2af1 loci. (A) The 0.59 Mb targeted region, defined by the Abcg1 and U2af1
genes, contains 12 genes as shown from the image captured from the UCSC genome browser (http://genome.ucsc.edu). (B) The targeting vectors containing a
loxP site (green arrow), a selectable antibiotic resistance gene (puro, neo), and part of the Hprt gene (30 or 50 Hprt, red arrows) were integrated successively in the
Abcg1 locus and between the Cbs and U2af1 genes [Cis(Abcg1tm1Yah–U2af1tm1Yah)]. (C) Checking of the new genetic configurations by Southern blot. In
embryonic stem cells (left panel), southern analysis with AscI digestion and probe A reveals a 10 kb fragment for the Cis(Abcg1tm1Yah–U2af1tm1Yah) allele,
a 6.6 kb for the Ms2Yah allele and two bands at 10 and 13.4 kb for the Ts1Yah locus. In mice (middle), the Ms2Yah allele was checked with probe B,
showing an additional HindIII fragment of 9.8 kb compared with the wild-type allele (12.9 kb), whereas the Ts1Yah locus (right panel) was confirmed using
the BglII enzyme and probe A. (D) Interphase FISH analysis with BAC probes that map in the Abcg1–U2af1 region (red) and outside (green). The wild-type
(2n) showed two red and two green adjacent signals, whereas nuclei from Ms2Yah (Ms) showed two green and only one red signal due to the deletion of the
Abcg1–U2af1 region. The Ts1Yah (Ts) nuclei showed two green and three red signal due to the duplication. As: AscI, Bg: BglII, H: HindIII, puro: puromycin,
neo: neomycin.
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ated in the open-field test. The absence of significant differences
in distance traveled and number of rears between Ts1Yah and
their wild-type littermates in the first session (S1) indicates
that the aneuploid mice have a normal motor and exploratory
activity and no anxiety-induced locomotor activity (Fig. 2C).
No additional abnormal behavior was noticed. Twenty-four
hours later in the second session (S2), a reduction in activity
due to habituation was observed in both genotype, but the
Ts1Yah were significantly more active than wild-types, as
shown by the higher levels of horizontal and vertical activities
[21% increase in travelled distance (P , 0.01, Student’s
t-test) and 44% increase in rearing (P, 0.01, Student’s t-test)
with respect to wild-types]. This observation suggested
reduced inter-session habituation in Ts animals. Habituation is
a sign of non-associative learning in which there is a progressive
diminution of behavioral response probability with repetition of
a stimulus or to an environment, which is thus partly altered in
Ts1Yah mice. Since anxiety behavior or emotional reactivity
could be implicated, the Ts1Yah mice were tested for
anxiety-related behavior on the elevated plus maze. No signifi-
cant differences between Ts and wild-types were found (Sup-
plementary Material, Fig. S1A) in anxiety-related behavior.
Short-term memory was assessed by recording spontaneous
alternation in the Y-maze test (Fig. 2D). The Y-maze test is
based on the innate preference of animals to explore an arm
that has not been previously explored, a behavior that, if
occurred with a frequency greater than 50%, is called spon-
taneous alternation. In our experiments, the total number of
arm entries recorded during a single 5 min session did not
differ significantly between aneuploid and diploid mice, con-
firming that the level of activity is unaffected in Ts1Yah
mice (Fig. 2D). However, the percentage of alternation
between the three arms was significantly lower in the
Ts1Yah mice compared with their diploid littermates (P,
0.05, Student’s t-test). This low alternation indicates a deficit
in short-term memory in Ts1Yah mice.
On the basis of the previous studies in other DS mouse
models, we analyzed the hippocampal cognitive traits in
Figure 2. Motor activity and behavioral analysis of Ts1Yah mice. Rotarod (A) Mean+SEM of the latencies to fall from the rotarod and (B) number of shock
received on the treadmill by Ts1Yah (black circles) and wild-type males (gray circles) during training sessions (T1 and T2) and along test sessions (S1–S6) with
increasing fixed rotational speeds (4, 10, 14, 19, 24, and 34 r.p.m.). Ts1Yah mice do not show significant motor coordination, nor motor learning impairment
[Rotarod: F(1,28) ¼ 0.222 P ¼ 0.641; Treadmill: F(1,28) ¼ 0.347 P ¼ 0.561, repeated measures ANOVA]. (C) Mean+SEM of the traveled distance (in meters
(m) upper panel) and number of rears (lower panel) performed by Ts1Yah mice (black bars) and wild-type mice (gray bars) in an open-field during two sessions
of 30 min (S1 and S2) with 24 h inter-session interval. During the first session (S1), similar locomotor activity was observed in Ts1Yah mice, but in the second
session (S2), a reduced habituation was detected as shown by the 21% increase in travelled distance (P, 0.001, P , 0.01, Student’s t-test) and 44%
increased rearing activity (P , 0.01, Student’s t-test) for the Ts1Yah mice compared with their wild-type peers. (D) Mean+SEM percentage of alternation
(A; upper panel) and number of arm entries (AE; lower panel) of Ts1Yah (black bars) and wild-type mice (gray bars) during a single 5 min session in a Y-maze.
Normal motor activity with lower percentage of alternation was found for Ts1Yah mice (P , 0.05, Student’s t-test). In the novel object recognition test (E),
working memory is altered in Ts1Yah at 1 h retention. The discrimination index (N2F/NþF) reveals a significant deficit in short-term recognition for Ts1Yah
mice (black) compared with the wild-type mice (gray) (Kruskal–Wallis one-way analysis P, 0.05).
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Ts1Yah using the NOR designed for the assessment of short-
term recognition memory and the MWM tests that serve to
analyze recognition and visuo-spatial learning and memory
(17,29). The NOR test is based on the natural tendency of
rodents to investigate a novel object instead of a familiar
one. The choice to explore the novel object as well as the reac-
tivation of exploration after object displacement reflects the
use of learning and (recognition) memory processes. No sig-
nificant difference in the time spent to explore two identical
objects in the NOR was observed during the training session
between Ts1Yah and euploid (Eu) mice, and all the mice
had the same curiosity and motivation for this task (data not
shown). However, Ts1Yah mice spent less time in exploring
the novel object in the second session as indicated by the dis-
crimination index (Fig. 2E; Supplementary Material,
Fig. S1B), suggesting that Ts mice have impaired short-term
recognition memory.
Visual–spatial learning and memory was explored using the
hidden-platform MWM. In this task, animals learned to locate
the position of the submerged platform by using extra-maze
spatial cues. During the pre-training phase of the test,
Ts1Yah mice learned to locate the visible platform, equally
to wild-types, indicating no procedural learning impairment.
However, during the learning phase, with the hidden platform,
Ts1Yah mice displayed enhanced ability to locate its position,
as indicated by the increased permanence in the target quad-
rant along sessions and the more focused search (Fig. 3A
and B), which resulted in a significant shift to the left of the
acquisition curve (P , 0.001, repeated measures ANOVA;
Fig. 3C), thus indicating more efficient learning. Moreover,
estimation of other more specific learning indexes such as
the Whishaw index (defined as percentage path inside the
optimal corridor to reach the platform) indicated the use of
more efficient learning strategies in Ts mice (Fig. 3D).
Figure 3. Analysis of hippocampal-dependent explicit spatial learning and memory. (A) Learning strategies are shown in the graphical representation of swim-
ming paths of wild-type versus Ts1Yah mice along MWM acquisition sessions (A1–A5). Upper panel: Color-coded histograms representing occupancy of wild-
type (upper panel) and trisomic (Ts) (lower panel) mice during acquisition sessions of the MWM task. Color scale is given on the right of the histograms. The
Ts1Yah mice focused their search in the trained location earlier and more efficiently than wild-type. Lower panel: representative swim paths of a wild-type and a
Ts mouse illustrating that controls swam more irregularly than the Ts. (B) Ts1Yah mice learned the platform position more quickly than wild-types, as shown by
the steeper acquisition curve (latency to find the platform) although significant differences in escape latency were observed in session 3 [F(1,28) ¼ 7.018 P ¼
0.014, ANOVA]. As a consequence, Ts1Yah mice showed a significantly higher improvement along sessions (F(1,28) ¼ 5.671 P ¼ 0.025, Repeated Measures
ANOVA). (C) Permanence time in quadrants, trial by trial, during acquisition sessions. Ts1Yah mice show a steeper slope than 2n mice, indicating a better
performance in learning task. (D) The Whishaw index, defined as percentage path inside an optimal corridor to reach the platform, confirmed better performance
of Ts1Yah than control mice [F(1,28) ¼ 8.513 P ¼ 0.007, Repeated Measures ANOVA].
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No changes in swimming speed or thigmotaxic behavior were
observed (Supplementary Material, Fig. S2A and B), thus dis-
carding any anxiety-related effects in the phenotypes
observed. In the removal session, we found a tendency to
increase the distance travelled in the trained quadrant in Ts
mice (Supplementary Material, Fig. S2C), although it did
not reach statistical significance. Accordingly, the learning
process was similar between both groups in the reversal
session. As a conclusion, we found that the increased ability
of the Ts1Yah mice is specific for visual–spatial learning
with almost no impact on spatial memory.
In vivo electrophysiological activity in the CA1 of Ts mice
Hippocampal LTP, a form of synaptic plasticity, provides a
putative physiological basis for hippocampus-dependent learn-
ing and memory (30,31). We hence assessed synaptic function
in the Ts1Yah hippocampus by recording the activity-
dependent changes at the CA3–CA1 synapse in conscious
mice. Both diploid and Ts mice presented similar increases
in the slope of field excitatory post-synaptic potentials
(fEPSP) evoked at the CA1 area following the presentation
of single pulses of increasing intensity at the ipsilateral Schaf-
fer collaterals (Fig. 4A and B). In both genotypes, these
relationships were fitted by sigmoid curves suggesting a
normal functioning of the CA3–CA1 synapse. It is known
that the synaptic facilitation evoked by the presentation of a
pair of pulses is a typical presynaptic short-term plastic prop-
erty of the hippocampal CA3–CA1 synapse, which has been
related to neurotransmitter release (32). As illustrated in
Figure 4, control and Ts1Yah presented a significant increase
of the response to the second pulse at short (20–100 ms) time
intervals. However, no genotype-dependent differences were
observed at any of the selected intervals, suggesting that short-
term plastic processes are not affected in Ts animals. For the
LTP study, after presenting the animal with the high-
frequency stimulation (HFS) protocol, recording sessions
were repeated 24 and 48 h later for 15 min each. Measurement
of LTP revealed larger and longer-lasting LTP responses in
Ts1Yah mice compared with their respective littermate con-
trols (Fig. 4C), even at the end of the recording time (48 h)
being significantly larger in Ts1Yah (200%) than in wild
Figure 4. Change in long-term potentiation in Ts1Yah mice compared with control littermate. (A) Wild-type (gray circles) and trisomic (black circles) mice
presented normal input/output curves. To this end, single (100 ms, biphasic) pulse was presented to Schaffer collaterals at increasing intensities (in mA),
while recording the evoked fEPSP at the CA1. Some fEPSPs collected from the four types of mouse are illustrated at the right. (B) There were no significant
differences in paired-pulse facilitation between wild-type (gray) and transgenic (black) mice. The data shown are mean+SEM slopes of the second fEPSP
expressed as a percentage of the first for six (10, 20, 40, 100, 200, 500) inter-pulse intervals. Some fEPSP paired traces collected from a representative
Ts1Yah mouse at different inter-pulse intervals (10–200 ms) are illustrated at the right. (C) At the top are illustrated examples of fEPSPs collected from selected
wild-type (gray) and Ts1Yah (black) animals before (baseline) and after (1–3) high-frequency stimulation (HFS) of Schaffer collaterals. The bottom graphs
illustrate the time course of LTP evoked in the CA1 area (fEPSP mean+SEM) following HFS for wild-type and transgenic mice. The HFS was presented
after 15 min of baseline recordings, at the time marked by the dashed line. The fEPSP is given as a percentage of the baseline (100%) slope. Although the
two groups presented a significant increase (ANOVA, two-tailed) in fEPSP slope following HFS when compared with baseline records, values collected
from the Ts1Yah group were significantly (P, 0.001; F(24,216) ¼ 25.278) larger than those collected from wt mice at the indicated times.
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types (115%) with respect to the baseline values. This result
provides a distinct link between certain forms of hippocampal
LTP and the enhanced visual–spatial learning detected in
Ts1Yah mice in the MWM.
Impact of copy number variation on expression of genes
located in the Abcg1–U2af1 genetic interval
In DS, changes in copy number are associated with alteration
of gene expression even though compensation effects have
been described (33–36). Thus, we investigated the transcrip-
tional levels of the genes located in the Abcg1–U2af1 interval
in both trisomy and monosomy models. Taqman real-time
quantitative PCR analysis was performed on samples derived
from cortex, thalamus-hypothalamus, hippocampus and cer-
ebellum of Ts1Yah, Ms2Yah (Ms) and euploid (2n) mice.
Abcg1 and U2af1 that were at the border of the region were
mostly unaffected, with an expression level 1, whereas all
the other expressed genes within the Abcg1–U2af1 region
were globally 0.5-fold under-expressed in Ms2Yah tissues,
and their expression was 1.5-fold increased in Ts1Yah
tissues (Fig. 5). Ubash3a, Tff2, Tff3 and Tmprss3 were
detected only in one sub-region of the mouse brain (hippo-
campus for Ubash3a; cerebellum for Tff2, Tff3 and Tmprss3)
with similar expression pattern in Ts and Ms (data not
shown). In addition, we measured expression levels of four
genes at the borders of the re-arrangement, namely Umodl1,
Abcg1, U2af1 and Cryaa (Fig. 5), three Hsa21 orthologous
genes from Mmu10 (Pfkl, Nnp1 and Cstb), eight Hsa21 ortho-
logous genes from Mmu16 (Erg, Pcp4, Dscam, Bace2, Gabpa,
Bach1, Runx1 and Sh3bgr; Supplementary Material, Fig. S3),
three Hsa21 orthologous genes from Mmu10 (Pfkl, Nnp1 and
Cstb) and six housekeeping genes used for input normalization
(data not shown). No significant change of gene expression
was observed for genes not located in the engineered interval
except for the Umodl1 gene whose expression was increased
substantially in the Ts thalamus (Fig. 5).
Next, we focused on the Cystathionine beta synthase (Cbs)
gene, which is overexpressed in all tested regions of the brain.
CBS catalyses the change of homocysteine toward cystathio-
nine and its deficiency causes homocystinuria (OMIN
236250), a disease associated with increased plasma homocys-
teine and mental retardation. Thus we checked whether the
altered gene expression modifies the accumulation or the
activity of the encoded protein. We determined the concen-
tration of the plasma homocysteine, the substrate of CBS
and showed a significant difference in Ms2Yah mice com-
pared with euploid and Ts1Yah mice (Fig. 6A). Levels of
homocysteine were significantly increased in Ms2Yah
females and males (P , 0,001, Student’s t-test) and decreased
in Ts1Yah males (P, 0,001, Student’s t-test), but not females
(P ¼ 0.628, Student’s t-test). These variations correlate with
the amount of CBS protein detected in the liver of aneuploid
mice (Fig. 6B). When compared with a similar level of
GADPH in the extract, level of CBS was decreased in the
Ms and increased in the Ts liver. Similarly, overexpression
of Cbs in DS patients leads to a decrease in homocysteine
levels (37). As expected most of the genes located in the
Abcg1–U2af1 genetic interval were sensitive to gene dosage
in the brain of both aneuploid models but a few including
Rsph1, Slc37a1, Pde9a, Ndufv3, Pknox1 and Cbs were overex-
pressed in the Ts hippocampus.
DISCUSSION
The aim of this study was to analyze the contribution of the
Abcg1–U2af1 region from the telomeric part of the Hsa21
to the DS phenotype. To this end, we generated two new
models by chromosome engineering, a trisomy and a monos-
omy for the 0.59 Mb Mmu17 Abcg1–U2af1 region that is
homologous to a distal part of Hsa21. In this report, we
focused our interest on the Ts model. We found that the
Figure 5. Expression of genes from the Abcg1–U2af1 region in four different
Ts1Yah, euploid (Eu) and Ms2Yah mice brain tissues. Box plots of normalized
expression levels of 11 Mmu17 genes expressed in the four tissues analyzed
(Cortex, Thalamus-Hypothalamus, Hippocampus and Cerebellum). The
X-axis is normalized expression values relative to the mean of Eu mice, the
Y-axis is the three genotype groups (2n ¼ Eu, Ms ¼Ms2Yah and Ts ¼
Ts1Yah mice). Each panel represents a gene (shown on right).
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trisomy of the Abcg1–U2af1 region modifies cognitive
performance and the neurophysiology of the hippocampus.
Furthermore, expression of the genes located in the Abcg1–
U2af1 interval was shown to be sensitive to copy number.
Behavioral and neurological analysis of the Ts1Yah mice
has shown a clear but complex cognitive phenotype that com-
bines altered habituation (a form of non-associative learning),
and spontaneous alternation, reflecting short-term spatial
memory and short-term recognition memory in the NOR.
However, trisomy of the interval improved moderately the
performance in spatial learning in the spatial version of the
MWM. Our model mimics DS patients for their reduced
attention and their alterations in processes involved in some
forms of explicit memory that require the integrity of hippo-
campal functions (38–40). DS is characterized by a complex
neuropsychological profile where some abilities are more
impaired than others. In particular, DS people and DS
mouse models such as the Ts65Dn (17,20,41–43) show a
specific impairment in hippocampal-based declarative learning
and memory. Similar to the Ts65Dn model (17), Ts1Yah mice
perform poorly in the NOR task that has been related to a poor
hippocampal-based declarative memory function, a hallmark
of DS cognitive characteristics. However, the role of the hip-
pocampus in object recognition memory processes is unclear
since conflicting results have been found in lesion studies of
both primates and rodents. In the current view, even though
the hippocampus is involved in object recognition memory,
parahippocampal structures (e.g. perirhinal cortex) are suffi-
cient to support object recognition memory over short-
retention intervals. Interestingly, object recognition is not
altered in Ts1Cje mice (9) but long-lasting NOR is modified
in the Ts1Rhr (44). Thus, at least several independent
genetic intervals, some located on Mmu16, and one located
in the Abcg1–U2af1 region should interact in patients. Inter-
estingly, control of this trait might be even more complex as
the Tc1 mouse model displays impaired short-term memory
of object, whereas their long-term memory of object in
not affected (10,26). Taken together, these results could
reflect the region-specificity of hippocampal versus para-
hippocampal genetic alteration in the different models. More
surprisingly, spatial reference learning was improved in the
Ts1Yah mice. The observed differences between NOR and
MWM with the Ts1Yah was due to impairment of short-term
memory and relative improvement of long-term memory and
learning.
The MWM result was unexpected as other models, such as
Ts65Dn and Tc1 mice are defective in learning in this test
(13,20,26,42,43,45–50); a defect similar to the hippocampal
deficit observed in DS patients (38,40,51). Furthermore, the
hippocampus of Ts65Dn or Tc1 mice was affected for their
structure, plasticity, growth, response to signaling pathways
and LTP (19,52–57). In Ts65Dn, defects in LTP in the
dentate gyrus has been related to enhanced inhibitory synaptic
transmission (53,54,58), whereas Tc1 showed a more reduced
early LTP that was restored 24 h after the initial stimulation
(26). In contrast to both models, performances in the MWM
task and LTP are surprisingly enhanced in the Ts1Yah mice.
One seeming contradiction in our experiments would be the
reduced performance in the NOR that is also partially depen-
dent on hippocampal function. However, although both NOR
and MWM assess hippocampus-dependent functions, each
test puts specific cognitive demands on the animal, including
spatial exploration and the formation of associations
between spatial and non-spatial cues. These data reinforced
the idea that separate domains mediate recognition versus
spatial memory (59). In this regards, some evidence suggests
a local processing deficit in DS construction, in which percep-
tual impairment in processing local forms, a global attention
bias, or even an abnormality in the interaction between
global and local levels may be involved (60).
Increased performance in the MWM was supported by
higher and long-lasting LTP. Somehow both results suggested
Figure 6. Detection of plasma homocysteine and CBS protein levels in
Ms2Yah and Ts1Yah mice. (A) Mean+SEM plasma levels of total homocys-
teine (mmol/l) in females and males Ms2Yah (white box) (n ¼ 15 females and
7 males), Ts1Yah (black box; n ¼ 15 females and 14 males) and their wild-
type littermate (gray box; Ms2Yah wild-type littermate: n ¼ 7 females and
9 males and for the Ts1Yah wild-type littermate: n ¼ 15 females and 15
males) at 3 months of age. (B) Western blots of CBS in the liver of
Ms2Yah (Ms), control (2n) and Ts1Yah (Ts) adult mice (3 months of age).
Equal amounts (20 mg) of protein extracts were loaded in each lane and the
same blot was incubated with an antibody against GADPH to normalize
loading (P , 0.001, Student’s t-test).
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a convergence of mechanisms leading to improved
hippocampal-dependent spatial memory and LTP, and dis-
sociation of hippocampal function between spatial memory,
novelty discrimination and working memory in this model.
Such an increase in LTP could results from alterations in sig-
naling pathways or in GABAergic mechanisms rather than an
alteration in LTP machinery itself (61). Reduced LTP has been
observed in the Ts65Dn and to some extent in the Ts1Cje and
Ts1Rhr models (44,58,62–65) but less severely in the Tc1
mouse, a more complete Ts model (26). These results
provide evidence for supporting a genetic mechanism affect-
ing the severity of cognitive deficits observed in DS patients.
Somehow, allelic variations of the genes from the Abcg1–
U2af1 and other regions on Mmu16 or Mmu10 should affect
the DS cognitive phenotypes that can be either severe or mod-
erate. In addition, controlling the copy number and the
expression of the genes from the Abcg1–U2af1 region could
also affect the learning and memory in normal population.
By the use of two new genetic configurations, we were able
to determine the consequences of copy number variation on
the expression of genes from the genetic interval located at
the borders or on other homologous region to the Hsa21.
Our current analysis, on four different subregions of the
brain, showed that all expressed genes from the engineered
interval follow the expected transcription level based on
copy number, with a decrease of the expression ratio to
0.5 in Ms and an increase to 1.5 in Ts tissues. Our
results are similar to those described in other Ts or Ms
mouse models (33,66–73) and in human DS patients (34–
36,74–76). Two genes located on each side of the borders
were studied. Only the expression of Umodl1 was changed
in the thalamus of Ts mice, suggesting an altered regulation
of transcription of the gene due to the engineered segmental
duplication. Similar changes were described in other diseases
depending on large genomic rearrangements (77–79). A cor-
relation between protein level and substrate concentration
was established in both Ms and Ts males versus control
animals and confirmed the parallel, for Cbs, between gene
expression level and protein level. Interestingly, the homocys-
teine level in Ts females was not affected in our study a result
similar to some obtained in human T21 patients at the adult
stage (80,81) but controversial to others obtained in younger
individuals (37).
The present data suggest that the telomeric part of Hsa21
contain genes involved in the global and local perception,
attention and construction deficits in DS. In comparison with
the previous DS models, whereas the Ts65Dn mouse shows
deficiencies across both domains, Ts1Cje appear to have
deficiencies restricted to only the spatially oriented domain
(9,17,41). Thus, the Abcg1–U2af1 region should contain at
least one gene that is implicated in hippocampus-dependent
spatial learning and LTP and whose overexpression leads to
a gain-of-function phenotype. Most of the genes found
within Abcg1–U2af1 have not been functionally characterized
and no non-coding RNAs, including miRNAs, have been
reported so far in the region. A few genes are associated
with behavioral changes, such as polymorphisms of Pde9a
with major depressive disorder (82) and Cbs deficiency with
mental retardation in homocystinuria. Such an allelic variation
of genes from the Abcg1–U2af1 region in the human
population might alter differently the behavioral deficit of
the DS patients and also might help to consider the hypothesis
drawn from the human genetics analysis. Further experiments
will be necessary to pinpoint that gene(s) might be responsible
for the Ts1Yah phenotype, such as rescue experiments with
single gene inactivation.
In conclusion, we report that the Mmu17 region orthologous
to Hsa21, which had not been previously analyzed, contributes
to the cognitive phenotypes observed in DS individuals.
Mouse models that are Ts for other non-overlapping Hsa21
orthologous regions also show cognitive phenotypes: the
Ts65Dn mouse displays deficiencies in both NOR and
MWM, whereas the Ts1Cje model appears to have
deficiencies restricted to only the spatially oriented domain
(17). Learning and memory phenotype in both trisomies is
linked to changes in the structure and the circuitry develop-
ment of their hippocampus and of their cortical pyramidal
layer, associated to reduced LTP and long-term depression
(19,52–57). In this report, we found that trisomy of the
Abcg1–U2af1 interval also impacted the hippocampal func-
tion in a more sophisticated way, disturbing short-term
memory while facilitating the spatial learning and LTP. All
these data combined suggest that the variable DS cognitive
phenotypes are likely to result from the complex interactions
of several genes or regions which can have negative or
even positive contributions to cognitive performance
(7,8,17,24,83). The data presented here show that variation
in copy number should not only be considered as deleterious
or susceptibility factors, but also can have advantageous or
protective factors (12). Substantial progress has recently
been made concerning several genes and pathways involved
in DS pathogenesis (11), but this study highlights the complex-
ity of this disorder. We showed that trisomy of a specific inter-
val can both contribute to decrease in certain cognitive
function and to an improvement of another one. Thus the con-
tribution of the different regions of Hsa21 needs to be further
evaluated to pinpoint genes modulating DS traits. This will not
only decipher the pathophysiology of the disease but also help
to characterize pathways controlling hippocampal-dependent
learning and memory that could be targeted to rescue DS
alterations or to improve normal condition.
MATERIALS AND METHODS
Generating the Ms2Yah and Ts1Yah mouse strains
The Abcg1 and U2af1 targeting vectors were isolated, respect-
ively, from the 50Hprt and 30Hprt libraries (84) and inserted by
homologous recombination in HM-1 Hprt-deficient ES cells
(85). Subsequently, a transient expression of the Cre recombi-
nase provided ES cells with three different configurations
(Fig. 1). We obtained ES cell clones carrying two loxP sites
in the Abcg1 and U2af1 loci in a cis configuration, which
were named Cis(Abcg1tm1Yah–U2af1tm1Yah), ES cells with a
deletion of the Abcg1–U2af1 region, the Ms2Yah clone and
the Ts1Yah clone which provide a duplication of this region.
Ms2Yah and Ts1Yah clones were injected into C57BL/6J
blastocysts to generate chimera. These animals were crossed
with C57BL/6J mice to obtain the corresponding mouse line.
The Ms2Yah [B6.129Del(17Abcg1–U2af1)] and the Ts1Yah
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[B6.129Dup(17Abcg1–U2af1)] were generated on 129/Ola
and backcrossed on the C57BL/6J genetic background up to
N7 in this study.
Southern blot and fluorescence in situ hybridization
(FISH) analysis
Between 5 and 10 mg of genomic tail or ES cell DNA extracts
were digested with the appropriate enzyme and separated by
electrophoresis through 0.7% agarose gel. Southern blot analy-
sis was performed as described by Besson et al. (73).
Interphase nuclei were recovered by affixing of a frozen/
defrosted sample of kidney on a slide. Mouse BAC clones
were chosen to be located inside (RP23-148M13) or outside
(RP23-50P6) the Abcg1–U2af1 region; and 1 mg of mouse
BAC DNA was used to generate DNA probes labeled by
nick translation with DIG-dUTP (for 148M13) and biotin-
dUTP (for 50P6). Detection was achieved by the use of both
antidigoxigenin–rhodamine and avidin–fluorescein antibodies
(Roche, Mannheim, Germany). The slide was mounted with
vectashield medium containing DAPI 40,6 diamidino-2-
phenylindole (Vector Laboratories, Burlingame, CA, USA).
Images were analyzed by SmartCapture2F (Digital Scientific,
Cambridge, UK) using a Zeiss AxioPlanII microscope
equipped with a cooled camera (Photometrics, Tuscon, USA).
Behavioral analysis
Experiments were divided into two series. Groups of 15 Ts1Yah
and 15 wild-type male mice at N4 backcross level on C57BL6/J
(3 months of age) were tested in a first level behavioral analysis:
SHIRPA, open-field, Y- and elevated plus mazes. A second
groups of 15 Ts1Yah and 14 wild-type male mice at N5 back-
cross level (5 months of age; 30–35 g) were involved in a
more specific analysis: Rotarod, treadmill, NOR and MWM.
All the behavioral testing was conducted by the same exper-
imenter in an isolated room and at the same time of the day
(between 8:30 a.m. and 3:30 p.m.). Behavioral experimenters
were blinded as to the genetic status of the animals. Mice
were group housed (3–4 littermate mice per cage) in standard
macrolon cages under a 12 h light–dark schedule (lights on at
8:00 a.m.) in controlled environmental conditions of humidity
(60%) and temperature (22+ 28C) with free access to food
and water. All experimental protocols involving the use of
animals were performed in accordance with recommendations
for the proper care and use of laboratory animals and were per-
formed under authorization of the local Ethics Committee for
Animal Experimentation (PRBB 1998/031 OV/2004/184
PNT) through the regulations and policies governing the Care
and Use of Laboratory Animals (Law 5/1995 of the Catalonian
Government, EU directive no. 86/609 and Council of Europe
Convention ETS123, EU decree 2001-486 and regulations of
the National Institutes of Health No. A5388-01) (USA). All
investigators involved in animal experimentation have the
appropriate training (Department de Medi Ambient i Habitatge,
decret 214/1997). The CRG is authorized to work with
genetically modified organisms (Operacions d’Utilitzacio´
Confinada d’OGM A/ES/05/I-13 and A/ES/05/14). The exper-
iments followed the recommendations from the standard
operating procedures developed by the Eumorphia network
(http://www.eumorphia.org). Detailed protocols are listed in
Supplementary Materials and Methods.
LTP induction
Animals were anesthetized with 0.8–3% halothane delivered
from a calibrated Fluotec 5 (Fluotec-Ohmeda, Tewksbury,
MA, USA) vaporizer at a flow rate of 1–4 l/min oxygen.
Animals were implanted with bipolar stimulating electrodes
aimed at the right Schaffer collateral-commissural pathway
of the dorsal hippocampus [2 mm lateral and 1.5 mm pos-
terior to Bregma; depth from brain surface, 1.0–1.5 mm
(86)] and with two recording electrodes aimed at the ipsilat-
eral stratum radiatum underneath the CA1 area (1.2 mm
lateral and 2.2 mm posterior to Bregma; depth from brain
surface, 1.0–1.5 mm). These electrodes were made of
50 mm Teflon-coated tungsten wire (Advent Research
Materials Ltd, Eynsham, England). The final position of hip-
pocampal electrodes was determined using as a guide the
field potential depth profile evoked by paired (40 ms of inter-
val) pulses presented at the Schaffer collateral pathway (87).
A bare silver wire (0.1 mm) was affixed to the skull as a
ground. The four wires were connected to a four-pin socket
and the socket was fixed to the skull with the help of two
small screws and dental cement [see Ref. (87) for details].
A total of ten successful animals at N5 backcross level
(about 8 months of age) were prepared for each experimental
group.
fEPSPs were recorded with Grass P511 differential ampli-
fiers through a high-impedance probe (2  1012 V, 10 pF).
Electrical stimulus presented to Schaffer collaterals consisted
of 100 ms, square, biphasic pulses presented alone, paired or
in trains. Stimulus intensities ranged from 0.02 to 500 mA
for the construction of the input/output curves. For paired
pulse facilitation, the stimulus intensity was set well below
the threshold for evoking a population spike, usually 35% of
the intensity necessary for evoking a maximum fEPSP
response (88). Paired pulses were presented at six different
pulse intervals (10, 20, 40, 100, 200, and 500). The stimulus
intensity was also set at 35% of its asymptotic value for
LTP induction. An additional criterion for selecting stimulus
intensity for LTP induction was that a second stimulus, pre-
sented 40 ms after a conditioning pulse, evoked a larger
(.20%) synaptic field potential than the first (89). For LTP
induction, each animal was presented with a HFS protocol
consisting of five trains (200 Hz, 100 ms) of pulses at a rate
of 1/s. This protocol was presented six times in total, at inter-
vals of 1 min. The 100 ms, square, biphasic pulses used to
evoke LTP were applied at the same intensity used for the
single pulse presented following CS presentation. Further
details of this chronic preparation can be found elsewhere
(87). Statistical analyses were carried out using two-way
repeated measure ANOVA. Factors were time versus fEPSP
slopes, being time a repeated measure. Contrast analysis was
added to further study significant differences.
Gene expression analysis
Cerebellum, thalamus-hypothalamus, hippocampus and
cortex were isolated from 15 male mice at 3 month of age
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(six Ts; five Ms and four Eu) and flash frozen. Total RNA
was prepared using Trizol (Invitrogen) according to the man-
ufacturer’s instructions. The quality of all RNA samples was
checked using an Agilent 2100 Bioanalyzer (Agilent Tech-
nologies). Total RNA was converted to cDNA using Super-
script II (Invitrogen) primed with poly d(T). For each
sample in the study, 1 mg of total RNA was converted to
cDNA. On the basis of Ensembl annotation (http://www
.ensembl.org/index.html), we considered for study 14 genes
mapping on Mmu17, between the Abcg1 and U2af1 genes
where the loxP sites were inserted. Assays for the Umodl1,
Abcg1, U2af1 and Cryaa genes were also designed to
check the expression, the genes mapping to the borders of
the insertions/deletions. In addition, we included assays for
17 non-Mmu17 genes. Among these, three genes for each
tissue were selected for normalization and the remaining
genes were used as additional controls. Selection of normal-
ization genes was performed with GeNorm software (90).
The list of the primers used is available on request.
Taqman assays were designed using the program PrimerEx-
press v 2.0 (Applied Biosystems) with default parameters.
Where possible, assays were designed to span an intron,
and for the majority of the cases this was possible. Non
intron-spanning assay (Pknox1) was tested in standard þ/2
RT reactions of RNA samples for genomic contamination;
and no amplification was observed. Assay efficiencies were
calculated using five four-fold serial dilutions of a pool of
mouse brain, liver and testis (BLT) cDNAs as described
(36). When transcripts were not expressed in BLT, efficien-
cies were tested in heart, thalamus, cerebellum and total
embryo. Two genes (Pknox1 and Pde9a) did not pass our
efficiency criteria threshold (between 0.95 and 1.05) and
were re-designed successfully, whereas Tff1 was excluded
from the analysis because the expression was not detected
in any of the tissues studied giving a total of 15 Mmu17
genes and 17 non-Mmu17 genes. Amplicon sequences were
checked by BLAST against the mouse genome to ensure
that they were specific for the gene being assayed.
HPLC-purified FAM-TAMRA-labeled double-dye Taqman
probes were obtained from Sigma-Genosys (UK). All reac-
tions used qPCR mastermix from ABgene (Epsom, UK).
All PCRs were set up using a Biomek 2000 robot
(Beckman), in a 10 ml volume in 384-well plates with six
replicates per sample and ran in an ABI 7900 Sequence
Detection System (Applied Biosystems) with the following
conditions: 508C for 2 min, 958C for 10 min and 50 cycles
of 958C 15 s/608C for 1 min. In total, 11 520 qRT–PCR
reactions were performed. Raw Cycle threshold (CT)
values were obtained using SDS 2.1 software (Applied
Biosystems). Baseline values were automatically determined
and threshold values were manually adjusted for each gene.
Values with a deviation of +0.25 CT with respect to the
median were considered outliers and excluded. Transcripts
that amplified with a CT value greater than 37.9 were not
included in the analysis. Each gene was rescaled
using the mean expression value of control samples to give
a relative normalized value. Data handling and
normalizations were performed using Excel (Microsoft Cor-
poration) and R (R Foundation, see Web Resources). To
assess the differences in gene expression values between
Ts, Ms and Eu samples, we performed the Kruskal–Wallis
(KW) test.
Homocysteine measurement and western blotting
Blood samples were collected on fasting mice in tubes con-
taining lithium heparin. After centrifugation, the plasma was
separated and stored at 2208C. Total homocysteine concen-
tration was measured on IMX (Abbott Laboratory) equipment
using the commercially available ‘Abbott homocysteine
assay’, a fluorescence polarization immunoassay from
Abbott Diagnostics according to the manufacturer’s instruc-
tions. Twenty microgram of total protein from liver extracts
were electrophoretically separated in SDS–polyacrylamide
gels (12%) and then transferred to nitrocellulose membrane
(17 V) over night at room temperature. Non-specific binding
sites were blocked with 5% skim milk powder in Tween
Tris buffer saline 1 h at room temperature. Immunostaining
was carried out with a goat polyclonal anti-Cbs and anti-
Gapdh antibodies (Santa Cruz Biotechnology), followed by
secondary anti-goat IgG conjugated with horseradish peroxi-
dase (Santa Cruz Biotechnology). The immunoreactions
were visualized by ECL chemiluminescence system (Amer-
sham Biosciences) and exposure to ECL Hyperfilm (GE
healthcare) for 1–5 min.
Statistical analysis
Results were processed for statistical analysis using the Sigma
Plot software (Sigma) unless otherwise indicated. Data are rep-
resented as the mean+SEM. All acquired behavioral data were
analyzed using a one-way ANOVA test, with genotype as the
independent variable. Data collected were also analyzed with
general linear model with session as repeated measure. When
appropriate, the parametric Fisher–Student t-test was applied
otherwise the non-parametric KW test was used. Significant
threshold was P , 0.05 or otherwise indicated.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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